PolyOne Expands its Reach with Advanced Composite Materials at JEC World 2019 PolyOne Showcases More Than Materials for Healthcare Applications at MD&M West 2019 Move Over, Metal: PolyOne Launches Surround™ EMI/RFI Shielding Formulations

PolyOne to Begin Specialty Engineered Material Production in India ANAHEIM, Calif. – PolyOne Advanced Composites, a new platform within PolyOne’s Specialty Engineered Materials business, is exhibiting for the New Textile Printing Inks Collaboration Announced Between PolyOne Wilflex and Ryonet

PolyOne Showcases Regulatory-Compliant, Robust Polymer Solutions at Wire Southeast Asia 2017 Premium Sporting Knife Manufacturer Relies on PolyOne’s Bergamid™ Nylon to Extend its Brand Message Relies on PolyOne GlasArmor™ Panels

PolyOne PolyOne PolyOne

PolyOne PolyOne's PolyOne

PolyOne PolyOne PolyOne

PolyOne PolyOne PolyOne

The foresight and expertise of PolyOne’s Synthetic Esters team, combined with PolyOne’s manufacturing agility, enabled rapid development, production and delivery of a cost-effective alternative.” About PolyOne PolyOne Corporation, with 2015 revenues of $3.4 billion, is a premier provider of specialized polymer materials, services and solutions.   Photo Credit: ©ThinkStock.com/PolyOne 

She will serve on the Environmental, Health and Safety committee.  PolyOne PolyOne

Scope included legacy PolyOne operations. D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A L B Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% H I G H F R E E C A S H F L OW C O N V E R S I O N Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of April 27, 2021 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi e n t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of April 27, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.